Institute for Precision Health
Research areas
The Institute for Precision Health is discovering, developing and testing diagnostics, novel medicines and technologies to improve healthcare provision, patient treatment and clinical outcomes. Key to our delivery programme is the Leicester Drug Discovery and Diagnostics (LD3) team
We focus on our areas of excellence in:
- Cancer
- Cardiovascular diseases
- Data innovation and ethnic health
- Diabetes and lifestyle
- Environment and health
- Infectious diseases
- Respiratory diseases
We invest in inter-disciplinary research and platform technologies that include:
- Clinical imaging
- Data analytics
- Drug and diagnostics discovery
- Environmental impact on disease
- Genomics and next generation sequencing
- Health and biomedical informatics
- Liquid biopsy
- Metabolomics
- Phenomics
- Proteomics